Benzinga | Feb 23, 2021 08:12AM EST

Kiniksa Pharmaceuticals Q4 EPS $(0.79) Down From $(0.58) YoY

Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported quarterly losses of $(0.79) per share. This is a 36.21 percent decrease over losses of $(0.58) per share from the same period last year.